Nanos Medical (Shanghai) Co., Ltd.
PrivateLast Round
Strategic
Feb 1, 2025
Total Funding Raised
$41.27M
Company Overview
Nanos Medical (Shanghai) Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Strategic round in February 2025.
Nanos Medical (Shanghai) Co., Ltd. is a medical technology company that develops, manufactures, and markets minimally invasive interventional medical devices, with a primary focus on otorhinolaryngology (ENT) and head and neck surgery solutions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanos Medical (Shanghai) Co., Ltd. Comparables
Compare Nanos Medical (Shanghai) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hefei Breath Medical Technology Co., Ltd. | 85% | |
| Innovia Medical | 75% | |
| Xi'an GAOTON Technology Development Co., Ltd. | 74% |
For institutional investors. Book with your work email.
Nanos Medical (Shanghai) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Feb 1, 2025 | ||||
| Series D | Jul 1, 2021 |
For institutional investors. Book with your work email.
Nanos Medical (Shanghai) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eight Roads Ventures | Series B |
| Marathon Venture Partners | Series C |
| F-Prime Capital | Series B |
| 6 Dimensions Capital | Series B |
| Yunfeng Capital | Series D |
| Qiming Venture Partners | Strategic |
| Sunshine Riverhead Capital Investment Management Co., Ltd. | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2025
$41.3M raised with Qiming Venture Partners leading.
- Jul 1, 2021
Raised Series D round with Yunfeng Capital.
For institutional investors. Book with your work email.
Nanos Medical (Shanghai) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanos Medical (Shanghai) Co., Ltd.'s valuation, stock price, and market status.
Is Nanos Medical (Shanghai) Co., Ltd. a public or private company?
Nanos Medical (Shanghai) Co., Ltd. is a private company.
What is the current stock price of Nanos Medical (Shanghai) Co., Ltd.?
Nanos Medical (Shanghai) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Nanos Medical (Shanghai) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanos Medical (Shanghai) Co., Ltd. worth (valuation)?
Valuation information for Nanos Medical (Shanghai) Co., Ltd. is not publicly available.
Can I buy Nanos Medical (Shanghai) Co., Ltd. stock?
Nanos Medical (Shanghai) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanos Medical (Shanghai) Co., Ltd.'s last funding round?
Nanos Medical (Shanghai) Co., Ltd.'s most recent funding round was Strategic on February 1, 2025.
Who are the main investors in Nanos Medical (Shanghai) Co., Ltd.?
Key investors in Nanos Medical (Shanghai) Co., Ltd. include Eight Roads Ventures, Qiming Venture Partners.
Will Nanos Medical (Shanghai) Co., Ltd. IPO soon?
No public IPO plans have been announced for Nanos Medical (Shanghai) Co., Ltd..
How can I track Nanos Medical (Shanghai) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Nanos Medical (Shanghai) Co., Ltd.'s shares on secondary markets.